Amanote Research
Register
Sign In
Pcn36 - The Effect of Introducing Nivolumab in the Adjuvant Treatment Setting of Malignant Melanoma
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.118
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
O. Blandy
K. Price
N. Kumar
Publisher
Elsevier BV
Related search
Adjuvant Radiation for Malignant Melanoma
Kansas Journal of Medicine
Malignant Melanoma Arising in the Setting of Epidermolysis Bullosa Simplex
JAMA Dermatology
Dermatology
Medicine
Prm187 - A Systematic Review of Utility Estimates in Melanoma in the Adjuvant Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm21 - Modelling Survival of Patients With Completely Resected Advanced Melanoma With Adjuvant Treatment of Nivolumab Versus Observation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Adjuvant and Neoadjuvant Treatment of Melanoma
Memo - Magazine of European Medical Oncology
Oncology
Hematology
An Update on the Safety of Nivolumab for the Treatment of Advanced Melanoma
Expert Opinion on Drug Safety
Medicine
Pharmacology
Impact of Different Surgical and Postoperative Adjuvant Treatment Modalities on Survival of Sinonasal Malignant Melanoma
BMC Cancer
Cancer Research
Oncology
Genetics
Surgical Treatment of Malignant Melanoma
The Diagnosis and Treatment of Malignant Melanoma of the Skin
Postgraduate Medical Journal
Medicine
